The Drug Enforcement Administration DEA proposes to establish the 2025 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act CSA and the assessment of annual needs for the list I chemicals ephedrine pseudoephedrine and phenylpropanolamine.